We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wall Street was upbeat last week with the S&P 500 adding 0.6%, the Dow Jones gaining 1.1% and the Nasdaq advancing 1.4%. The benchmark U.S. treasury yield started the week at 4.63%, hit a high of 4.69% and ended the week at 4.50%.
The Fed’s plan to slower the balance sheet tightening process and the release of downbeat jobs data (which triggered bets over sooner-than-expected rate cuts) dragged down bond yields last week. The U.S. economy added 175,000 jobs in April, well below Wall Street expectations of 240,000. Health care and social assistance led the way with a gain of 87,000 jobs.
Meanwhile, corporate earnings have been bullish with Apple and Amazon coming up with both line beats. The corporate commentaries released throughout the week indicated the importance of AI growth and investments (read: ETFs to Tap Amazon's Q1 Earnings Beat, AI Growth).
Meanwhile, crude oil ETF United States Oil Fund LP (USO - Free Report) dropped about 6.2% last week on weak demand growth and less supply worries emanated from the Gaza-Israel peace talk. Higher U.S. crude output too played its role in driving down the price of oil (read: Where Could Oil Go From Here? ETFs in Focus).
Against this backdrop, below we highlight winning leveraged ETFs of last week.
The U.S. benchmark treasury yield fell sharply last week. This boosted growth stocks and biotech technology. Novel drug launches, likely low rates and potential easy access to funds should buoy the zone in the near term.
Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares (EVAV) – Up 22.9%
Several electric vehicle stocks have been in sweet spot lately, as EV giant Tesla has surged post earnings. Chinese EV companies Nio and Xpeng have seen strong sales growth in 2024 despite massive price war. Nio stock was up 19% last week. Further, several auto companies are signing deals with Chinese tech companies to facilitate their innovations on AI and “smart cars.”
T-Rex 2X Long Apple Daily Target ETF (AAPX) – Up 16.8%
Apple stock gained 5.8% last week on upbeat earnings. Apple reported robust second-quarter fiscal 2024 results, wherein it beat estimates on both earnings and revenues. The iPhone manufacturer lifted its dividend payments and unveiled a record share buyback program despite the steep decline in iPhone sales (read: ETFs to Buy on Apple's Q2 Earnings Beat, Largest-Ever Buyback).
Apple, which lags behind its peer in adopting AI, is gearing up for significant events that are expected to shape its future trajectory. A media event scheduled for May 7 is anticipated to unveil new iPad models and the annual Worldwide Developers Conference (WWDC), starting Jun 10, is anticipated to provide AI-related announcements and insights into the company’s AI strategy.
Direxion Daily FTSE China Bull 3X Shares (YINN) – Up 16.5%
Despite the Chinese economy’s poor performance last year, global investors are returning to its equities this year. Compelling valuation, market restructuring, billions in buybacks, the AI boom and its impact on various industries have been boosting the space, of late. Foreign carmakers are joining hands with Chinese companies operating in artificial intelligence and other smart car technology. China tech ETF CQQQ added 6.4% last week while Alibaba and Baidu gaining about 7% and 8%, respectively (read: China Tech ETFs in Upbeat Momentum: Here's Why).
Shares of cannabis companies surged last week after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous schedule III drug. This indicates a moderate to low risk of physical and psychological dependence. Cannabis firms would stand to gain significantly as they would no longer fall under the purview of Section 280E of the U.S. federal tax code, presenting one of the most notable advantages.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Best Leveraged ETFs of Last Week
Wall Street was upbeat last week with the S&P 500 adding 0.6%, the Dow Jones gaining 1.1% and the Nasdaq advancing 1.4%. The benchmark U.S. treasury yield started the week at 4.63%, hit a high of 4.69% and ended the week at 4.50%.
The Fed’s plan to slower the balance sheet tightening process and the release of downbeat jobs data (which triggered bets over sooner-than-expected rate cuts) dragged down bond yields last week. The U.S. economy added 175,000 jobs in April, well below Wall Street expectations of 240,000. Health care and social assistance led the way with a gain of 87,000 jobs.
Meanwhile, corporate earnings have been bullish with Apple and Amazon coming up with both line beats. The corporate commentaries released throughout the week indicated the importance of AI growth and investments (read: ETFs to Tap Amazon's Q1 Earnings Beat, AI Growth).
Meanwhile, crude oil ETF United States Oil Fund LP (USO - Free Report) dropped about 6.2% last week on weak demand growth and less supply worries emanated from the Gaza-Israel peace talk. Higher U.S. crude output too played its role in driving down the price of oil (read: Where Could Oil Go From Here? ETFs in Focus).
Against this backdrop, below we highlight winning leveraged ETFs of last week.
ETF Areas in Focus
Direxion Daily S&P Biotech Bull 3x Shares (LABU) – Up 24.55%
The U.S. benchmark treasury yield fell sharply last week. This boosted growth stocks and biotech technology. Novel drug launches, likely low rates and potential easy access to funds should buoy the zone in the near term.
Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares (EVAV) – Up 22.9%
Several electric vehicle stocks have been in sweet spot lately, as EV giant Tesla has surged post earnings. Chinese EV companies Nio and Xpeng have seen strong sales growth in 2024 despite massive price war. Nio stock was up 19% last week. Further, several auto companies are signing deals with Chinese tech companies to facilitate their innovations on AI and “smart cars.”
T-Rex 2X Long Apple Daily Target ETF (AAPX) – Up 16.8%
Apple stock gained 5.8% last week on upbeat earnings. Apple reported robust second-quarter fiscal 2024 results, wherein it beat estimates on both earnings and revenues. The iPhone manufacturer lifted its dividend payments and unveiled a record share buyback program despite the steep decline in iPhone sales (read: ETFs to Buy on Apple's Q2 Earnings Beat, Largest-Ever Buyback).
Apple, which lags behind its peer in adopting AI, is gearing up for significant events that are expected to shape its future trajectory. A media event scheduled for May 7 is anticipated to unveil new iPad models and the annual Worldwide Developers Conference (WWDC), starting Jun 10, is anticipated to provide AI-related announcements and insights into the company’s AI strategy.
Direxion Daily FTSE China Bull 3X Shares (YINN) – Up 16.5%
Despite the Chinese economy’s poor performance last year, global investors are returning to its equities this year. Compelling valuation, market restructuring, billions in buybacks, the AI boom and its impact on various industries have been boosting the space, of late. Foreign carmakers are joining hands with Chinese companies operating in artificial intelligence and other smart car technology. China tech ETF CQQQ added 6.4% last week while Alibaba and Baidu gaining about 7% and 8%, respectively (read: China Tech ETFs in Upbeat Momentum: Here's Why).
AdvisorShares MSOS 2x Daily ETF (MSOX) – Up 14.1%
Shares of cannabis companies surged last week after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous schedule III drug. This indicates a moderate to low risk of physical and psychological dependence. Cannabis firms would stand to gain significantly as they would no longer fall under the purview of Section 280E of the U.S. federal tax code, presenting one of the most notable advantages.